# FDA Inspection 1320434 - LifeShare Blood Center - May 18, 2026

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/c22d57b0-ddb9-488a-8e76-509bbddf84b2
Source feed: FDA_Inspections

> FDA Inspection 1320434 for LifeShare Blood Center on May 18, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1320434
- Company Name: LifeShare Blood Center
- Inspection Date: 2026-05-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1277107 - 2025-02-05](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/e30cbf67-2c7c-4c44-998b-19652c1311d3)

Company: https://www.keypedia.com/companies/lifeshare-blood-center/8c1fe783-7867-412d-bb24-9afec8f9e26d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d